Grade My Investments
HomeFree Stock Grades › MLAB

Mesa Laboratories, Inc. (MLAB) Stock Grade

MLAB · Healthcare

A
Grade updated: July 18, 2026
Computed by the GradeMyInvestments scoring model from revenue growth, profitability, balance-sheet strength, and analyst targets.
Market Cap
$487.5M
P/E Ratio
72.6
Revenue Growth (YoY)
+3.4%
Net Margin
2.7%
Return on Equity
3.6%
Dividend Yield
0.7%

About Mesa Laboratories, Inc.'s fundamentals

Mesa Laboratories is a healthcare equipment and services company with a market capitalization of $487.5 million that is growing revenues modestly at 3.4% year-over-year. The company operates with a thin net profit margin of 2.7% and generates limited returns on shareholder equity at 3.6%, indicating operational challenges in converting sales into earnings. Trading at a P/E ratio of 72.6, the valuation is elevated relative to current profitability, while the company offers minimal income to shareholders through a 0.7% dividend yield.

Track MLAB free — no credit card required. Live grade + monthly AI report →